Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter

GLIA

Volumn 56, Issue 2, 2008, Pages 233-240

  Bakiri, Yamina ^a   Hamilton, Nicola B ^a   Káradóttir, Ragnhildur ^a   Attwell, David ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glia; Glutamate; Ischaemia; NMDA receptor; White matter

Indexed keywords

AMPA RECEPTOR; DIZOCILPINE; GLUTAMIC ACID; KAINIC ACID RECEPTOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; RAT STRAIN; WHITE MATTER;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MEMANTINE; MYELIN BASIC PROTEINS; N-METHYLASPARTATE; OLIGODENDROGLIA; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 37349030194     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20608     Document Type: Article

References (40)

1. Allen NJ, Káradóttir R, Attwell D. 2005. A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J Neurosci 25:848-859.
2. Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N, Fern R. 2007. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 27:334-347.
3. Blanpied TA, Boeckman FA, Aizenman E, Johnson JW. 1997. Trapping block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77:309-323.
4. Bolton S, Butt AM. The optic nerve: A model for axon-glia interactions. 2005. J Pharmacol Toxicol Methods 51:221-233.
5. Craig A, Ling Luo N, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA. 2003. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231-240.
6. Dewar D, Underhill SM, Goldberg MP. 2003. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 23:263-274.
7. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. 2004. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: A protective role for topiramate. J Neurosci 24:4412-4420.
8. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. 2000. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20:9235-9241.
9. Frankiewicz T, Potier B, Bashir ZI, Collingridge GL, Parsons CG. 1996. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol 117:689-697.
10. García-Barcina JM, Matute C. 1996. Expression of kainate-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Eur J Neurosci 8:2379-2387.
11. Gill R, Foster AC, Woodruff GN. 1988. MK-801 is neuroprotective in gerbils when given during the post-ischaemic period. Neuroscience 25:847-855.
12. Káradóttir R, Attwell D. 2006. Combining patch-clamping of cells in brain slices with immunocytochemical labelling to define cell type and developmental stage. Nat Protoc 1:1977-1986.
13. Káradóttir R, Attwell D. 2007. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 14:1426-1438.
14. Káradóttir R, Cavelier P, Bergersen L, Attwell D. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162-1166.
15. Lalo U, Pankratov Y, Kirchhoff F, North RA, Verhkratasky A. 2006. NMDA receptors mediate neuron-glia signaling in mouse cortical astrocytes. J Neurosci 26:2673-2683.
16. Li S, Mealing GA, Morley P, Stys PK. 1999. Novel injury mechanism in anoxia and trauma of spinal cord white matter: Glutamate release via reverse Na+-dependent glutamate transport. J Neurosci 19:RC16.
17. Lipton SA. 2006. NMDA receptors, glial cells and clinical medicine. Neuron 50:9-11.
18. Maneru C, Junque C, Salgado-Pineda P, Serra-Grabulosa JM, Bartres-Faz D, Ramirez-Ruiz B, Bargallo N, Tallada M, Botet F. 2003. Corpus callosum atrophy in adolescents with antecedents of moderate perinatal asphyxia. Brain Inj 17:1003-1009.
19. Matute C. 2006. Oligodendrocyte NMDA receptors: A novel therapeutic target. Trends Molec Med 12:289-292.
20. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV. 2001. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24:224-230.
21. 2+ channels encoded by mRNA from the adult corpus callosum Proc Natl Acad Sci USA 90:3270-3274.
22. McCarran WJ, Goldberg MP. 2007. White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. J Neurosci 27:4220-4229.
23. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK. 2006. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439:988-992.
24. Ouardouz M, Nikolaeva MA, Coderre E, Zamponi GW, McRory JE, Trapp BD, Yin X, Wang W, Woulfe J, Stys PK. 2003. Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 40,53-63.
25. Park E, Velumian AA, Fehlings MG. 2004. The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754-774.
26. Parsons CG, Danysz W, Quack G. 1999a. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data. Neuropharmacology 38:735-767.
27. Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G. 1999b. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: In vitro and in vivo characterization. Neuropharmacology 38:85-108.
28. Pitt D, Werner P, Raine CS. 2000. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67-70.
29. Ransom BR, Waxman SG, Davis PK. 1990. Anoxic injury of CNS white matter: Protective effect of ketamine. Neurology1399-1403.
30. Salter MG, Fern R. 2005. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438:1167-1171.
31. Schipke CG, Ohlemeyer C, Matyaash M, Nolte C, Kettenmann H, Kirchhoff F. 2001. Astrocytes of the mouse neocortex express functional N-methyl- D-aspartate receptors. FASEB J 15:1270-1272.
32. Smith T, Groom A, Zhu B, Turski L. 2000. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nature Medicine 6:62-66.
33. Stys PK. 2005. General mechanisms of axonal damage and its prevention. J Neurol Sci 233:3-13.
34. Tekkök SB, Goldberg MP. 2001. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21:4237-4248.
35. Tekkök SB, Ye Z, Ransom BR. 2007. Excitotoxic mechanism of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 27:1540-1552.
36. Tennekoon GI, Cohen SR, Price DL, McKhann GM. 1977. Myelinogenesis in optic nerve: A morphological, autoradiographic and biochemical analysis. J Cell Biol 72:604-616.
37. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562.
38. Wallström E, Diener P, Ljungdahl A, Khademi M, Nilsson CG, Olsson T. 1996. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J Neurol Sci 137:89-96.
39. Werner P, Pitt D, Raine CS 2001. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169-180.
40. Wrathall JR, Teng YD, Marriott R. 1997. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp Neurol 145:565-573.